Cargando…

Aggressive Prostate Cancer in Patients Treated with Active Surveillance

SIMPLE SUMMARY: Active surveillance is a strategy used to manage early-stage prostate cancer without immediate treatment, aiming to maintain patients’ quality of life. However, concerns remain about identifying “aggressive prostate cancer” within the active surveillance cohort, which refers to cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tohi, Yoichiro, Kato, Takuma, Sugimoto, Mikio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486407/ https://www.ncbi.nlm.nih.gov/pubmed/37686546 http://dx.doi.org/10.3390/cancers15174270

Ejemplares similares

Acute generalized exanthematous pustulosis during apalutamide treatment in a patient with prostate cancer
por: Honda, Tomoko, et al.
Publicado: (2022)

Efficacy and toxicity of intravesical Bacillus Calmette-Guérin therapy in elderly patients with non-muscle-invasive bladder cancer
por: Matsuoka, Yuki, et al.
Publicado: (2021)

Apalutamide‐associated skin rash in patients with prostate cancer: Histological evaluation by skin biopsy
por: Tohi, Yoichiro, et al.
Publicado: (2021)

The predictive factor for pathological downgrading after prostatectomy in patients with biopsy Gleason score 4+3 or 4+4 prostate cancer
por: Tohi, Yoichiro, et al.
Publicado: (2021)

Positive Culture Prior to Transperineal Prostate Biopsy Was Not Associated with Post-Biopsy Febrile Urinary Tract Infection Development
por: Tohi, Yoichiro, et al.
Publicado: (2021)

Incidental finding of extramammary Paget's disease during active surveillance for early‐stage prostate cancer in a prostate biopsy
por: Fujiwara, Kengo, et al.
Publicado: (2023)

Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study
por: Sugimoto, Mikio, et al.
Publicado: (2022)

Low quality of life in men with chronic prostatitis-like symptoms
por: Sugimoto, Mikio, et al.
Publicado: (2022)

Development and internal validation of a screening tool for chronic prostatitis (S-CP)
por: Tohi, Yoichiro, et al.
Publicado: (2023)

Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells
por: Zhang, Xia, et al.
Publicado: (2021)

Quantitative [(99m)Tc]Tc-MDP SPECT/CT correlated with [(18)F]NaF PET/CT for bone metastases in patients with prostate cancer
por: Tanaka, Kenichi, et al.
Publicado: (2022)

The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma
por: Yamasaki, Mari, et al.
Publicado: (2022)

Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer
por: Tohi, Yoichiro, et al.
Publicado: (2022)

Risk of progression following a negative biopsy in prostate cancer active surveillance
por: Beckmann, Kerri, et al.
Publicado: (2022)

A case of retroperitoneal vascular malformation
por: Matsuoka, Yuki, et al.
Publicado: (2018)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

Neuroendocrine and Aggressive-Variant Prostate Cancer
por: Spetsieris, Nicholas, et al.
Publicado: (2020)

Prostate cancer: a review of active surveillance
por: Lund, Lars, et al.
Publicado: (2014)

A case of Ewing sarcoma family tumor of the kidney treated with robotic-assisted partial nephrectomy
por: Suzuki, Issei, et al.
Publicado: (2019)

The impact of baseline [−2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort
por: Hirama, Hiromi, et al.
Publicado: (2013)

Active surveillance for prostate cancer
por: Shill, Daniela K., et al.
Publicado: (2021)

Active surveillance for low-risk prostate cancer
por: Klotz, Laurence
Publicado: (2012)

Current status of active surveillance in prostate cancer
por: Chung, Mun Su, et al.
Publicado: (2016)

The Role of MRI in Prostate Cancer Active Surveillance
por: Johnson, Linda M., et al.
Publicado: (2014)

Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
por: Olivier, Jonathan, et al.
Publicado: (2022)

Early Experience With Active Surveillance in Low-Risk Prostate Cancer Treated
por: Ha, Ji Yong, et al.
Publicado: (2014)

Perineuritis Successfully Treated with Early Aggressive Immunotherapy
por: Nakamura, Takumi, et al.
Publicado: (2019)

Novel approaches for the identification of biomarkers of aggressive prostate cancer
por: Kim, Yunee, et al.
Publicado: (2013)

Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
por: Eickelschulte, Samaneh, et al.
Publicado: (2022)

Active surveillance for prostate cancer
por: Dall’Era, Marc A., et al.
Publicado: (2018)

Green tea extract for prevention of prostate cancer progression in patients on active surveillance
por: Kumar, Nagi B., et al.
Publicado: (2018)

Applying precision medicine to the active surveillance of prostate cancer
por: Reichard, Chad A., et al.
Publicado: (2015)

Racial disparities and considerations for active surveillance of prostate cancer
por: Jiang, Song, et al.
Publicado: (2018)

Active Surveillance for Prostate Cancer: Past, Current, and Future Trends
por: de Vos, Ivo I., et al.
Publicado: (2023)

Contemporary approach to active surveillance for favorable risk prostate cancer
por: Klotz, Laurence
Publicado: (2019)

Prostate cancer aggressiveness and financial toxicity among prostate cancer patients
por: KC, Madhav, et al.
Publicado: (2022)

Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression
por: Rybak, Adrian P., et al.
Publicado: (2014)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
por: Merkens, Lina, et al.
Publicado: (2022)

Management of patients with advanced prostate cancer in Japan: ‘real-world’ consideration of the results from the Advanced Prostate Cancer Consensus Conference
por: Fujita, Kazutoshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r16napjoh5u0ttokjig00h0prb